According to a new market research study on “North America Synthetic Biology Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Products, Technology, and Application” is expected to reach US$ 15,223.61 million by 2028 from US$ 4,313.62 million in 2021. The market is estimated to grow at a CAGR of 19.7% from 2021 to 2028. The report provides trends prevailing in the North America synthetic biology market along with the drivers and restraints pertaining to the market growth. Growing investments in synthetic biology is the major factor driving the growth of the North America synthetic biology market. However, renewed regulations for biotechnology may hamper the growth of the market hinders the growth of North America synthetic biology market.
Download Sample PDF Copy: https://www.businessmarketinsi....ghts.com/sample/BMIR
The List of Companies - North America Synthetic Biology Market
Agilent Technologies, Inc.
Amyris
Codexis
Genscript Biotech corporation
Integrated DNA Technologies
Merck KGaA
New England Biolabs
Novozymes A/S
Thermo Fisher Scientific
Twist Bioscience
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
